SG64924A1 - Inhibiting photodecompostion of 3-substituted-2- oxindoles - Google Patents

Inhibiting photodecompostion of 3-substituted-2- oxindoles

Info

Publication number
SG64924A1
SG64924A1 SG1996009306A SG1996009306A SG64924A1 SG 64924 A1 SG64924 A1 SG 64924A1 SG 1996009306 A SG1996009306 A SG 1996009306A SG 1996009306 A SG1996009306 A SG 1996009306A SG 64924 A1 SG64924 A1 SG 64924A1
Authority
SG
Singapore
Prior art keywords
photodecompostion
oxindoles
inhibiting
substituted
inhibiting photodecompostion
Prior art date
Application number
SG1996009306A
Other languages
English (en)
Inventor
Sharon M Laughlin
Willard C Newlin Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SG64924A1 publication Critical patent/SG64924A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
SG1996009306A 1995-04-24 1996-04-19 Inhibiting photodecompostion of 3-substituted-2- oxindoles SG64924A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
SG64924A1 true SG64924A1 (en) 1999-05-25

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996009306A SG64924A1 (en) 1995-04-24 1996-04-19 Inhibiting photodecompostion of 3-substituted-2- oxindoles

Country Status (30)

Country Link
EP (1) EP0827399A1 (sv)
JP (1) JPH10506635A (sv)
KR (1) KR100189585B1 (sv)
CN (1) CN1053667C (sv)
AP (1) AP607A (sv)
AR (1) AR002728A1 (sv)
AU (1) AU692378B2 (sv)
BG (1) BG100531A (sv)
BR (1) BR9602024A (sv)
CO (1) CO4700418A1 (sv)
FI (1) FI973988A (sv)
HR (1) HRP960194A2 (sv)
HU (1) HU216544B (sv)
IL (1) IL117969A0 (sv)
IS (1) IS4339A (sv)
MA (1) MA23848A1 (sv)
NO (1) NO961622L (sv)
NZ (1) NZ286432A (sv)
OA (1) OA10286A (sv)
PE (1) PE34397A1 (sv)
RO (1) RO113305B1 (sv)
RU (1) RU2109510C1 (sv)
SG (1) SG64924A1 (sv)
SI (1) SI9600133A (sv)
SK (1) SK51296A3 (sv)
TR (1) TR199600300A2 (sv)
UA (1) UA42739C2 (sv)
WO (1) WO1996033701A1 (sv)
YU (1) YU25096A (sv)
ZA (1) ZA963210B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111526730B (zh) 2017-12-29 2024-02-23 卡夫食品集团品牌有限责任公司 使用天然稳定剂改善的水包油乳液的氧化稳定性

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
HU216544B (hu) 1999-07-28
JPH10506635A (ja) 1998-06-30
UA42739C2 (uk) 2001-11-15
BG100531A (en) 1997-06-30
HUP9601057A2 (en) 1997-04-28
AP9600787A0 (en) 1996-04-30
KR960037656A (ko) 1996-11-19
CN1139110A (zh) 1997-01-01
RU2109510C1 (ru) 1998-04-27
AU692378B2 (en) 1998-06-04
WO1996033701A1 (en) 1996-10-31
TR199600300A2 (tr) 1996-11-21
AR002728A1 (es) 1998-04-29
SI9600133A (en) 1996-10-31
EP0827399A1 (en) 1998-03-11
KR100189585B1 (ko) 1999-06-01
BR9602024A (pt) 1998-10-06
PE34397A1 (es) 1997-09-29
HUP9601057A3 (en) 1997-05-28
FI973988A0 (sv) 1997-10-17
CO4700418A1 (es) 1998-12-29
CN1053667C (zh) 2000-06-21
ZA963210B (en) 1997-10-23
IS4339A (is) 1996-10-25
YU25096A (sh) 1998-08-14
NO961622L (no) 1996-10-25
IL117969A0 (en) 1996-08-04
AU5085196A (en) 1996-11-07
MA23848A1 (fr) 1996-12-31
AP607A (en) 1997-08-27
NO961622D0 (no) 1996-04-23
OA10286A (en) 1997-09-19
RO113305B1 (ro) 1998-06-30
FI973988A (sv) 1997-10-17
NZ286432A (en) 1998-05-27
SK51296A3 (en) 1997-04-09
HRP960194A2 (en) 1998-02-28
HU9601057D0 (en) 1996-06-28

Similar Documents

Publication Publication Date Title
PL327569A1 (en) Promedications of thrombosin inhibitors
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
PL321759A1 (en) Novel thrombosin inhibitors
EP0835109A4 (en) PYRIDINONE-BASED THROMBIN INHIBITORS
GB9526560D0 (en) Use of 2-Amino-Heterocycles
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
HUP9601524A3 (en) Prodrugs of paclytaxel-derivatives
IL116924A0 (en) Preparation of n-aryl- and n-hetarylhydroxylamines
IL123320A0 (en) Detection of hypoprathyroidism
IL122338A0 (en) Methods of inhibiting phagocytosis
ZA96725B (en) Use of phenyclyclohexylcarboxamides
IL118574A0 (en) Methods of inhibiting melanoma
GB9621852D0 (en) Inhibition of scale
PL320114A1 (en) Phenyl-substituted fluoroderivatives of 4-azasteroides
ZA969429B (en) Amidinohydrazones of ketones
GB9510563D0 (en) Well inhibition
IL117786A (en) Preparation of alpha-bisoximes
HUT76555A (en) Derivatives of trans apovincaminic-acid-esters
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
ZA963825B (en) Composition of matter
IL118238A0 (en) Synthesis of benzoquinolinones
ZA962440B (en) Destressing of railtracks
GB9521509D0 (en) Inhibition of scale
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
IL115554A0 (en) Earthquake-proofing of structures